Abstract:
A compound of general formula (I), wherein, R11, R12, R13, R14, R15, W, Y, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
Abstract:
The invention relates to substituted hydroxybiphenyls, the derivatives and the physiologically acceptable salts thereof. The invention relates to the compounds of formula (I), wherein the substituents R1, R2 and A are defined as indicated, and to the physiologically acceptable salts thereof. The inventive compounds are suitable e.g. as hypoglycemic drugs and as drugs for use in the prevention and treatment of diabetes.
Abstract:
The present invention provides a production method including reacting a diphenylmethylene halide compound represented by the following formula (1) with a malonic acid diester compound represented by the following formula (2) in an organic solvent selected from N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone and N,N-dimethylformamide, in the presence of a base selected from an alkali metal hydride and an alkali metal t-butoxide to give a diester compound represented by the following formula (3), and then subjecting the diester compound to hydrolysis and decarboxylation to give a diphenylalanine compound represented by the following formula (4). According to the present invention, diphenylalanine compound (4) can be obtained industrially advantageously in a high yield.
wherein each symbol is as defined in the specification.
Abstract:
The present invention concerns novel derivatives of 1-phenylalkanecarboxylic acids, pharmaceutical compositions thereof, a process for their preparation and their use for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
Abstract:
The present invention provides a method represented by Scheme 1: wherein X represents I, Br, Cl, alkylsulfonate, or arylsulfonate; Z represents optionally substituted aryl, heteroaryl or alkenyl; catalyst comprises a copper atom or ion, and a ligand; base represents a Bronsted base; and R represents optionally substituted alkyl, cycloalkyl, aralkyl, heteroaralkyl, alkenylalkyl, or alkynylalkyl.
Abstract:
The invention concerns compounds of formula (I) wherein: R1 represents a radical of formula (a) or (b); Y represents a CH2 radical or a sulphur atom; R5 represents a hydroxy radical, an alkoxy radical, a NH-OH radical, or a N(R8)(R9) radical; and R6 represents an alkyl radical, an OR10 radical, a SR10 radical, or a (CH2)r-COR11 radical. Said compounds are useful as PPARη receptor activators in pharmaceutical compositions for use in human or veterinary medicine (in dermatology, as well as in the field of cardiovascular diseases, immune diseases and/or diseases related to lipid metabolism), or in cosmetic compositions.
Abstract:
The invention relates to novel C2 phenyl-substituted cyclic keto-enols of formula (I), in which W, X, Y, Z and CKE have the meanings as cited in the description. The invention also relates to methods for producing said C2 phenyl-substituted cyclic keto-enols and to their use as pesticides and herbicides.
Abstract:
Die Erfindung betrifft neue phenylsubstituierte cyclische Ketoenole der Formel (I) in welcher
Het für eine der Gruppen
steht, worin A, B, D, G, X und Z die in der Beschreibung angegebene Bedeutung haben, mehrere Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
Abstract:
Prevention or therapy of inflammatory diseases caused by invasion of leukocytes such as monocytes, lymphocytes and eosinophils, by providing a substance which inhibits cell adhesion via an adhesion molecule, especially adhesion molecule VLA-4, is disclosed. A group of carboxylic acid derivatives represented by, for example, and adhesion molecule inhibitors comprising the same as an effective ingredient were provided.
Abstract:
The present invention aims at providing important intermediates used in production of a phenylalkanoic acid amide compound showing an excellent fungicidal effect; and novel and simple processes for producing such an intermediate or a raw material compound used in production of the intermediate. The present invention relates to a process for producing an amide compound represented by the following general formula [wherein R is an alkyl group, a cycloalkyl group, a haloalkyl group, an aryl group, a substituted aryl group, an arylalkyl group, a substituted arylalkyl group, an (aryl)(alkoxy)alkyl group or a (substituted aryl)(alkoxy)alkyl group; R 1 and R 2 are each independently an alkyl group, a cycloalkyl group, a haloalkyl group, an arylalkyl group, a substituted arylalkyl group, an aryl group, a substituted aryl group or a hydrogen atom, and may bond with each other to form a ring together with the carbon atom with which they bond; and R 3 is an alkyl group, a cycloalkyl group, a haloalkyl group, an arylalkyl group, a substituted arylalkyl group, an aryl group, a substituted aryl group or a hydrogen atom], which process comprises reacting a nitrile compound represented by the following general formula (wherein R, R 1 and R 2 each have the same definition as given above) with an acid to give rise to intramolecular ring closure to obtain an oxazolinone compound represented by the following general formula (wherein R, R 1 and R 2 each have the same definition as given above), and reacting the oxazolinone compound with a carboxy compound represented by the following general formula (wherein Y is a hydrogen atom, a carboxyl group or a salt of the carboxyl group; and R 3 has the same definition as given above) in the presence of a base.